Cargando…
The impact of a human IGF-II analog ([Leu(27)]IGF-II) on fetal growth in a mouse model of fetal growth restriction
Enhancing placental insulin-like growth factor (IGF) availability appears to be an attractive strategy for improving outcomes in fetal growth restriction (FGR). Our approach was the novel use of [Leu(27)]IGF-II, a human IGF-II analog that binds the IGF-II clearance receptor IGF-IIR in fetal growth-r...
Autores principales: | Charnock, Jayne C., Dilworth, Mark R., Aplin, John D., Sibley, Colin P., Westwood, Melissa, Crocker, Ian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Physiological Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675800/ https://www.ncbi.nlm.nih.gov/pubmed/26530156 http://dx.doi.org/10.1152/ajpendo.00379.2015 |
Ejemplares similares
-
Crossing mice deficient in eNOS with placental-specific Igf2 knockout mice: A new model of fetal growth restriction
por: Dilworth, M.R., et al.
Publicado: (2012) -
Pomegranate Juice Supplementation Alters Utero-Placental Vascular Function and Fetal Growth in the eNOS(−/−) Mouse Model of Fetal Growth Restriction
por: Finn-Sell, Sarah L., et al.
Publicado: (2018) -
Melatonin Increases Fetal Weight in Wild-Type Mice but Not in Mouse Models of Fetal Growth Restriction
por: Renshall, Lewis J., et al.
Publicado: (2018) -
Human placental uptake of glutamine and glutamate is reduced in fetal growth restriction
por: McIntyre, Kirsty R., et al.
Publicado: (2020) -
Sildenafil Citrate Increases Fetal Weight in a Mouse Model of Fetal Growth Restriction with a Normal Vascular Phenotype
por: Dilworth, Mark Robert, et al.
Publicado: (2013)